KW

Kwangdong Healthbio Co., Ltd.

086220 | KO

Overview

Corporate Details

ISIN(s):
KR7086220001
LEI:
Country:
South Korea
Address:
충청북도 청원군 오창읍 양청송대길 39(송대리), 오창읍
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-04 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-25 00:00
AGM Information
정기주주총회결과
Korean 15.2 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-17 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 436.1 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 114.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.1 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.4 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.6 KB
2024-12-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-08-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.3 KB
2024-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.6 KB

Automate Your Workflow. Get a real-time feed of all Kwangdong Healthbio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kwangdong Healthbio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kwangdong Healthbio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea
334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore
950210
Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
Probi Logo
Develops and manufactures clinically proven probiotics for B2B supplement & nutrition partners.
Sweden
PROB
Develops scientifically validated probiotics for cardiometabolic health for consumers & partners.
United Kingdom
PBX
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea
296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.